Xconomy Xchange: The Genetics Institute Impact

Genetics Institute is one of those names from the original biotech boom of the early 1980s that faded from the headlines a long time ago. But 15 years after GI was acquired by Wyeth (now part of Pfizer), this pioneering Boston biotech company is still causing ripples in the Boston biotech community-having recruited, inspired, and provided an essential training ground for a generation of young scientists and business people. Xconomy will bring together some of the leading GI alumni for The Genetic Institute Impact, a lively evening of reminiscing, networking, and brainstorming about what’s ahead for Boston biotech.

Register here.

Confirmed Speakers:
Gabriel Schmergel, former Genetics Institute CEO
Mark Ptashne, Genetics Institute Co-founder, Ludwig Chair of Molecular Biology, Memorial Sloan-Kettering Cancer Center
Tom Maniatis, Genetics Institute Co-founder, Professor and Chair, Biochemistry and Molecular Biophysics, Columbia University
Tony Evnin, Partner, Venrock Associates
Tuan Ha-Ngoc, CEO, Aveo Pharmaceuticals
Adelene Perkins, CEO, Infinity Pharmaceuticals
John Knopf, CEO, Acceleron Pharma
Abbie Celniker, CEO, Eleven Biotherapeutics
Sha Mi, Distinguished Investigator, Discovery Neurobiology, Biogen Idec

Registration & Networking: 4:30 – 5:30 pm
Program: 5:30 – 6:15 pm
Networking reception: 6:15 – 7:30 pm

Koch Institute
Alexandria Real Estate Equities Aveo Pharmaceuticals
Cubist Pharmaceuticals Infinity Pharmaceuticals Medidata